Car T-Cells In The Treatment Landscape Of Mantle Cell Lymphoma

CAR T-Cells in the Treatment Landscape of Mantle Cell Lymphoma

Targeted Oncology

The Curative Potential of CAR-T Cell Therapy in Mantle Cell Lymphoma

Dr. Martin on Potential for CAR T-Cell Therapy in MCL Landscape

Dr. Wang on CAR T-Cell Therapy Resistance in MCL

Challenges in using CAR-T therapy & BTK inhibitors in patients with R/R MCL

VJHemOnc – Video Journal of Hematology & HemOnc

CAR-T therapy for high-risk MCL patients

VJHemOnc – Video Journal of Hematology & HemOnc

The UK treatment landscape of mantle cell lymphoma

VJHemOnc – Video Journal of Hematology & HemOnc

Will CAR T-cell therapy change the treatment landscape for MCL?

An overview of CAR-T therapy in DLBCL and MCL

VJHemOnc – Video Journal of Hematology & HemOnc

Lymphoma: Overview of Chimeric Antigen Receptor (CAR) T cells

Harvard Medical School Continuing Education

Updates on the use of CAR-T therapy in mantle cell lymphoma and follicular lymphoma

VJHemOnc – Video Journal of Hematology & HemOnc

Dr. Martin on the Frontline Treatment Landscape of MCL

CAR T-cell therapy approved for mantle cell lymphoma

Dana-Farber Cancer Institute

Advancements in treating MCL

VJHemOnc – Video Journal of Hematology & HemOnc

Future directions for CAR T-cell therapy in MCL

VJHemOnc – Video Journal of Hematology & HemOnc

Dr. Leslie on the Development of CAR T-Cell Therapy in DLBCL and MCL

Dr. Rule on the Future Treatment Paradigm in MCL

Exploring Targeted and CAR T-Cell Therapies on the Horizon for MCL

Targeted Oncology

CAR T-Cell Therapy a ‘Really Exciting’ Development in Treatment of Lymphomas

Diane's story: CAR-T cell milestone

Nebraska Medicine Nebraska Medical Center